Manuscripts

Search by keyword, year, or author name.

Showing 1554 manuscripts.

The Pharmacokinetics and Safety of Zidovudine in the Third Trimester of Pregnancy for Women Infected With Human Immunodeficiency Virus and Their Infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group Study (Protocol 082)

Mary Jo O'Sullivan. The Pharmacokinetics and Safety of Zidovudine in the Third Trimester of Pregnancy for Women Infected With Human Immunodeficiency Virus and Their Infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group Study (Protocol 082). American Journal of Obstetrics and Gynecology. 1993. 168: 1510-1516.

Year

1993

Journal

American Journal of Obstetrics and Gynecology

Enhanced p24 Antigen Detection in Sera from HIV-Infected Children

E. Walter. Enhanced p24 Antigen Detection in Sera from HIV-Infected Children. Pediatric Infectious Disease Journal. 1993. 12: 94-96.

Year

1993

Journal

Pediatric Infectious Disease Journal

Uric acid and didanosine compliance in AIDS clinical trials: an analysis of AIDS Clinical Trials Group protocols 116A and 116B/117.

D. Richardson, Song-Heng Liou, James O. Kahn. Uric acid and didanosine compliance in AIDS clinical trials: an analysis of AIDS Clinical Trials Group protocols 116A and 116B/117.. Journal of Acquired Immune Deficiency Syndromes. 1993. 6: 1212-23.

Year

1993

Journal

Journal of Acquired Immune Deficiency Syndromes

2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients

A. Berger, Joseph Arezzo, Herbert H. Schaumburg, Gail Skowron, Thomas C. Merigan, Sam Bozzette, Douglas D. Richman, Whaijen Soo. 2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology. 1993. 43: 358-62.

Year

1993

Journal

Neurology

Human immunodeficiency virus infection in pregnant women under care at AIDS clinical trials centers in the United States

Pamela Stratton, Lynne M. Mofenson, Anne Willoughby. Human immunodeficiency virus infection in pregnant women under care at AIDS clinical trials centers in the United States. Obstetrics and Gynecology. 1993. 79: 364-8.

Year

1993

Journal

Obstetrics and Gynecology

Potential of Population Pharmacokinetics to Reduce the Frequency of Blood Sampling Required for Estimating Kinetic Parameters in Neonates

L. Collart, Terrence F. Blaschke, F. Boucher, C. Prober. Potential of Population Pharmacokinetics to Reduce the Frequency of Blood Sampling Required for Estimating Kinetic Parameters in Neonates. Developmental Pharmacology and Therapeutics. 1992. 18: 71-80.

Year

1992

Journal

Developmental Pharmacology and Therapeutics

Histoplasmosis - diagnosis and ,anagement

L. Joseph Wheat. Histoplasmosis - diagnosis and ,anagement. Infectious Diseases in Clinical Practice. 1992. 1: 287-90.

Year

1992

Journal

Infectious Diseases in Clinical Practice

Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid

L. Joseph Wheat, Patricia A. Connolly, Brian Williams, Kathleen Connolly, R. Blair, Marilyn S. Bartlett, Michelle M. Durkin. Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid. American Review of Respiratory Diseases. 1992. 145: 1421-4.

Year

1992

Journal

American Review of Respiratory Diseases

Immune Abnormalities and Control of AIDS

John L. Fahey. Immune Abnormalities and Control of AIDS. Progress in Allergy and Clinical Immunology. 1992. 2: 276-81.

Year

1992

Journal

Progress in Allergy and Clinical Immunology

The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia

J. Mohle-Boetani, S. K. Akula, Mark Holodniy, David Katzenstein, Gabriel Garcia. The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia. Western Journal of Medicine. 1992. 156: 303-6.

Year

1992

Journal

Western Journal of Medicine